Evidence map›Paper›PMID 36712356›Full record

ArticlePNAS nexus2022

Anticipatory countering of motor challenges by premovement activation of orexin neurons.

Dane Donegan, Daria Peleg-Raibstein, Olivier Lambercy, Denis Burdakov

Registry-linked trialAbstract read
In one paragraph

Article in PNAS nexus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06294509 (Feasibility and Effects of Transcutaneous Auricular Vagus Nerve Stimulation Timings in a Sensorimotor Task), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06294509 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Feasibility and Effects of Transcutaneous Auricular Vagus Nerve Stimulation Timings in a Sensorimotor Task

TypeinterventionalSponsorOlivier LambercyRan2024 to 2025Enrolled75ConditionsHealthyArmsin-house developed transcutaneous auricular Vagus Nerve Stimulation device
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dane DoneganDepartment of Health Sciences and Technology, Swiss Federal Institute of Technology - ETH Zürich, Schorenstrasse 16, 8603 Schwerzenbach, Switzerland.
Daria Peleg-RaibsteinDepartment of Health Sciences and Technology, Swiss Federal Institute of Technology - ETH Zürich, Schorenstrasse 16, 8603 Schwerzenbach, Switzerland.
Olivier LambercyDepartment of Health Sciences and Technology, Swiss Federal Institute of Technology - ETH Zürich, Schorenstrasse 16, 8603 Schwerzenbach, Switzerland.
Denis BurdakovDepartment of Health Sciences and Technology, Swiss Federal Institute of Technology - ETH Zürich, Schorenstrasse 16, 8603 Schwerzenbach, Switzerland.ORCID https://orcid.org/0000-0002-9134-9165

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Countering upcoming challenges with anticipatory movements is a fundamental function of the brain, whose neural implementations remain poorly defined. Recently, premovement neural activation was found outside canonical premotor areas, in the hypothalamic hypocretin/orexin neurons (HONs). The purpose of this hypothalamic activation is unknown. By studying precisely defined mouse-robot interactions, here we show that the premovement HON activity correlates with experience-dependent emergence of anticipatory movements that counter imminent motor challenges. Through targeted, bidirectional optogenetic interference, we demonstrate that the premovement HON activation governs the anticipatory movements. These findings advance our understanding of the behavioral and cognitive impact of temporally defined HON signals and may provide important insights into healthy adaptive movements.

Indexed as

hypothalamusmotor controlpredictive controlskilled movements

Identifiers

PMID36712356
PMCPMC9802298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.